Importantly, elevated levels of S100A8 and S100A9 were found in the ductal fluid of patients with pancreatic cancer, and the high expression levels of both proteins were associated with a median survival time that was nearly halved in comparison with that of patients without similarly elevated levels. This evidence concerns the gene S100A9 and familial pancreatic carcinoma.